Highly Restricted T Cell Repertoire Shaped by a Single Major Histocompatibility Complex-Peptide Ligand in the Presence of a Single Rearranged T Cell Receptor beta  Chain

By Yoshinori Fukui,*Dagger Osamu Hashimoto,* Ayumi Inayoshi,* Takahiro Gyotoku,* Tetsuro Sano,* Takahiro Koga,* Toshifumi Gushima,* and Takehiko Sasazuki*Dagger

From the * Department of Genetics, Medical Institute of Bioregulation, Kyushu University, and Dagger  Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Fukuoka 812-8582, Japan

    Abstract
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The T cell repertoire is shaped by positive and negative selection of thymocytes through the interaction of alpha /beta -T cell receptors (TCR) with self-peptides bound to self-major histocompatibility complex (MHC) molecules. However, the involvement of specific TCR-peptide contacts in positive selection remains unclear. By fixing TCR-beta chains with a single rearranged TCR-beta irrelevant to the selecting ligand, we show here that T cells selected to mature on a single MHC-peptide complex express highly restricted TCR-alpha chains in terms of Valpha usage and amino acid residue of their CDR3 loops, whereas such restriction was not observed with those selected by the same MHC with diverse sets of self-peptides including this peptide. Thus, we visualized the TCR structure required to survive positive selection directed by this single ligand. Our findings provide definitive evidence that specific recognition of self-peptides by TCR could be involved in positive selection of thymocytes.

Key words: positive selectionsingle major histocompatibility complex-peptide complexsingle rearranged T cell receptor beta  chainT cell repertoiretransgenic knockout mice
    Introduction
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Although the diversity of alpha /beta -TCR theoretically reaches 1015 by random rearrangement of five gene segments (Valpha , Jalpha , Vbeta , Dbeta , and Jbeta ) and random nucleotide addition (1), mature T cells express highly selected TCR in that they exhibit tolerance to self-antigenic peptides and restriction by self-MHC molecules. This mainly results from two reciprocal selection processes, positive and negative selection, acting during T cell development in the thymus. Positive selection is the process that induces differentiation of CD4+CD8+ immature thymocytes into CD4-CD8+ or CD4+CD8- mature thymocytes that mount immune response on foreign antigenic peptides bound to self-MHC molecules in the periphery, only when their TCR recognize self-MHC class I or class II molecules in the thymic environment (2- 7). On the other hand, negative selection is the process that eliminates immature thymocytes bearing TCR specific for self-peptides bound to self-MHC molecules (8).

Although it is widely accepted that self-peptides play a central role in negative selection, the role of self-peptides in positive selection has been the subject of considerable debate (13, 14). This issue was first directly addressed for positive selection of CD8+ T cells using fetal thymic organ cultures derived from mutant mouse strains where a particular MHC class I-peptide complex is expressed by exogenously adding a given peptide to the culture (15). More recently, several groups developed in vivo experimental systems focusing on the role of self-peptides in positive selection of CD4+ T cells, by creating mouse strains that express MHC class II molecules predominantly occupied with a single peptide (20). The conclusions deduced from these in vitro and in vivo studies for positive selection of CD8+ or CD4+ T cells are largely in agreement: whereas limited numbers of self-peptides bound to a given MHC molecule promoted the positive selection of T cells expressing diverse sets of TCR-alpha /beta with no obvious structural features, this complex could not be a positively selecting ligand for T cells expressing a particular transgenic TCR-alpha /beta that is selected to mature on the same MHC molecule with a normal array of self-peptides (25). This might reflect the weak but specific recognition of selecting peptides by TCR-alpha /beta in positive selection. However, experiments using TCR-alpha /beta transgenic mice could not exclude the possibility that side chains of the peptides interfere with the interaction of the analyzed TCR-alpha /beta with MHC molecule that would be essentially required for positive selection (29). In this respect, it would be important to assess whether specific TCR-peptide contacts are involved in positive selection, under physiological conditions where developing thymocytes express diverse sets of TCR-alpha /beta . Sant'Angelo et al. (30) recently addressed this issue by analyzing a particular Valpha -Jalpha segment in mice lacking H-2M (H-2M0/0)1 that catalyzes the dissociation of invariant chain-derived class II-associated peptide, CLIP, in the presence of a single rearranged TCR-beta chain. Although this study has shown that alternation of self-peptide repertoire affects CDR3 length of the selected TCR-alpha repertoire, no remarkable bias for amino acid composition of their CDR3 loops could be deduced. This might be a general feature of a positively selected T cell repertoire. Alternatively, this may be the result of the heterogeneity of selecting peptides, because it has been shown that peptides other than CLIP are bound to I-Ab molecules and contribute to the positive selection of CD4+ thymocytes in H-2M0/0 mice (26). In addition, it remains unclear from this study whether self-peptides involved in positive selection would affect variable gene segments of the selected TCR repertoire and this needs to be known if one is to better understand TCR-MHC-peptide interaction in positive selection process.

To clarify specific TCR-peptide contacts in positive selection, we analyzed the structure of TCR-alpha chains expressed on CD4+CD8- thymocytes selected to mature on a single ligand, I-Ab molecule covalently bound to Ealpha - derived peptide (Ealpha 52-68), in the presence of a single rearranged TCR-beta chain with irrelevant specificity for this ligand. Since positive selection is thought to be mediated through low affinity interaction of TCR-alpha /beta with MHC- peptide ligands (31), introduction of the TCR-beta chain irrelevant to I-Ab-Ealpha 52-68 complex would give us a better chance to reveal structural features of the associated TCR-alpha chains selected by this ligand. Therefore, we have selected the 2B4 TCR-beta chain derived from the TCR-alpha /beta specific for moth cytochrome c peptide bound to I-Ek or I-Eb molecules (32). By comparing the TCR-alpha repertoire shaped by I-Ab-Ealpha 52-68 complex with that by I-Ab molecules with a normal array of self-peptides, including Ealpha 52-68, in the presence 2B4 TCR-beta chain, we demonstrate here that expression of TCR-alpha chains with both particular Valpha segments and amino acid residue in their CDR3 loops is required to survive positive selection by this single ligand. These findings provide definitive evidence that specific TCR-peptide interaction could be involved in the positive selection of thymocytes.

    Materials and Methods
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Mice.

B2L mice that express the I-Abeta b chain covalently bound to Ealpha 52-68 but lack endogenous I-Abeta b and invariant chains (B2L DKO) have been described (24). B2L DKO mice were crossed with beta 2-microglobulin-deficient mice carrying H-2b haplotype (beta 20/0; Jackson Laboratories, Bar Harbor, ME), and B2L mice lacking the endogenous I-Abeta b chain, invariant chain, and beta 2-microglobulin were developed (B2L TKO). To develop B2L TKO/2B4beta mice, we crossed B2L TKO with mice transgenic for 2B4 TCR-beta chain that were maintained of C57BL/6 (B6) background (H-2b) in our facility (33). beta 20/0/ 2B4beta or Ealpha -B6/2B4beta mice were developed by crossing TKO/ 2B4beta mice with beta 20/0 or Ealpha transgenic B6 (Ealpha -B6) mice (34), respectively.

Antibodies.

The following mAbs were purchased from PharMingen (San Diego, CA): FITC-anti-CD8 (53-6.7); PE- anti-CD4 (RM4-5); biotinylated anti-NK1.1 (PK136); purified anti-CD24 (HSA, J11D); FITC-anti-TCR Valpha 2 (B20.1); Valpha 3.2 (RR3-16); Valpha 8 (B21.14); FITC-anti-TCR Vbeta 2 (B20.6); Vbeta 4 (KT4); Vbeta 5 (MR9-4); Vbeta 6 (RR4-7); Vbeta 7 (TR310); Vbeta 8 (MR5-2); Vbeta 9 (MR10-2); Vbeta 10 (B21.5); Vbeta 11 (RR3-15); Vbeta 12 (MR11-1); Vbeta 13 (MR12-3); Vbeta 14 (14-2); and biotinylated anti-TCR Vbeta 3 (KJ25). The mouse IgM mAb specific for CD8 used for the killing experiments were purchased from Meiji Institute of Health Science (Tokyo, Japan).

Flow Cytometry and Cell Sorting.

Single cell suspensions of thymocytes were prepared from mice 6-7 wk old and stained with FITC-anti-CD8, PE-anti-CD4, and biotinylated anti-NK1.1 or biotinylated anti-TCR Vbeta 3 mAb followed by streptavidin-Cy-Chrome (PharMingen). To assess the expression of TCR Valpha or Vbeta on CD4+CD8- thymocytes, thymocytes were incubated with anti-CD8 and anti-HSA IgM mAbs, followed by rabbit complement to remove immature thymocytes and CD4-CD8+ thymocytes. Viable cells recovered using Lympholyte-M (Cedarlane, Ontario, Canada) were stained with PE- anti-CD4 and FITC-anti-TCR Valpha or Vbeta mAb, with or without biotinylated anti-TCR Vbeta 3 followed by streptavidin-Cy-Chrome. Analyses were done on a FACScan® (Becton Dickinson, Mountain View, CA). For cell sorting, CD4+CD8- thymocytes were enriched as described above and were stained with PE-anti-CD4 and FITC-anti-CD8, with or without biotinylated anti-TCR Vbeta 3 mAb followed by streptavidin-Cy-Chrome. CD4+CD8- or CD4+CD8-Vbeta 3hi thymocytes (1-2 × 105) were sorted out using EPICS ELITE® (Coulter Corp., Hialeah, FL) or FACS® Vantage (Becton Dickinson) and were immediately placed in liquid nitrogen. All reagents were used at 10 µg/ml.

Mixed Lymphocyte Reaction.

Lymph node CD4+ T cells were prepared by eliminating CD8+ T cells and B cells from lymph node cells using anti-CD8 antibody followed by immunomagnetic beads coated with anti-Rat IgG antibody and those coated with anti-mouse IgG antibody (both from DYNAL, Oslo, Norway). The lymph node CD4+ T cells (1 × 105 cells/well) were cultured with irradiated spleen cells (1 × 106 cells/well) for 80 h and 1 µCi of [3H]thymidine was added during 16 h of the culture.

Anchored PCR.

The following oligonucleotides were used: PCalpha F1,TTGGGAGTCAAAGTCGGTGAAC; Calpha out, AACAGGCAGAGGGTGCTGTC; Calpha in, CTGAGACCGAGGATCTTTTAAC; AP, GGCCACGCGTCGACTAGTACGGGIIGGGIIGG GIIG; AUAP, GGCCACGCGTCGACTAGTAC.

Total cellular RNA was extracted from the sorted thymocytes using ISOGEN in the presence of 1 µl of Ethachinmate that facilitates the recovery of small amounts of nucleotides (both from Nippon Gene, Tokyo, Japan). The first strand cDNA synthesis primed with TCR Calpha -specific antisense oligonucleotide, PCalpha F1, was carried out using SuperScriptTM II reverse transcriptase (GIBCO BRL, Gaithersburg, MD) at 50°C. After treatment with RNase H and RNase I at 37°C for 30 min, the first strand cDNA was purified from unincorporated dNTPs and PCalpha F1 and was subjected to homopolymeric tailing using terminal deoxynucleotidyl transferase and dCTP. With this dC-tailed cDNA, several PCR were carried out using Calpha out and AP primers, under the following condition: 94°C (2 min), 1 cycle; 94°C (1 min), 55°C (1 min), and 72°C (2 min), 30 cycles; 72°C (5 min), 1 cycle. Then, the first PCR products were mixed and subjected to the second PCR using Calpha in and AUAP primers in the presence of TaqStart antibody (CLONTECH Laboratories, Inc., Palo Alto, CA), under the following condition: 94°C (2 min), 1 cycle; 94°C (1 min), 57°C (1 min), and 72°C (2 min), 30 cycles; 72°C (5 min), 1 cycle. When cDNA without dC-tailing was used, no visible band was obtained after the second PCR (data not shown).

Cloning and Sequencing of Anchored PCR Products.

The mixture of the second PCR products was ligated to pGMT-T Easy Vector (Promega Corporation, Madison, WI) and was used for the subsequent transformation of DH5alpha . Each colony was picked up and cultured in LB medium (100 µl) at 37°C for 5 h using 96-well U bottom plates, then the supernatant was subjected to PCR using AUAP and Calpha in2 (GAGACCGAGG ATCTTTTAACT) primers, under the following condition: 94°C (30 s), 1 cycle; 95°C (30 s) 68°C (3 min), 25 cycles. After removal of excess primers and dNTPs using centricon 100 (Amicon, Inc., Beverly, MA), the purified PCR products were labeled with dye terminator cycle sequencing using Calpha seq primer (AGACCGAGGATCTTTTAACT) and were analyzed on an ABI PRISMTM 377 DNA sequencer (Perkin-Elmer Corporation, Foster City, CA) according to standard protocols.

    Results
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
CD4+ T Cell Differentiation Directed by the I-Ab-Ealpha 52-68 Complex in Mice Lacking Endogenous MHC Class I and Class II Expressions.

Earlier, we had reported three lines of transgenic mice that had been developed by introducing the gene encoding I-Abeta b chain covalently bound to Ealpha 52-68 into mice lacking both endogenous I-Abeta b and invariant chains (DKO; reference 24). Evidence that the I-Ab molecule covalently bound to Ealpha 52-68 is expressed in these transgenic lines as a single species was obtained by complete inhibition by the mAb specific for I-Ab-Ealpha 52-68 complex of staining with an anti-I-Ab reagent, the inability of transgenic spleen cells to present other I-Ab-binding peptides, and the robust proliferative response of transgenic CD4+ T cells to wild-type I-Ab molecules with a normal array of self-peptides (24). In addition, a similar transgenic mouse line developed by Ignatowicz et al. (20) has been shown by the detailed analysis to present no other detectable self-peptides (26). However, we have found that CD4+CD8- thymocytes in these transgenic mice include NK1.1+ thymocytes that are selected by nonclassical MHC class I molecules such as CD1 (35, 36). To purify CD4+CD8- thymocytes selected to mature on I-Ab-Ealpha 52-68 complex from those selected by nonclassical and probably classical MHC class I molecules, we introduced null mutation of beta 2-microglobulin required for MHC class I expression into B2L DKO mice that expressed I-Ab-Ealpha 52-68 complex in the thymus at an intermediate level and showed most effective CD4+ T cell differentiation among three lines (24). Finally, B2L transgenic mice or nontransgenic mice lacking endogenous I-Abeta b, invariant chain, and beta 2-microglobulin (B2L TKO and TKO) were developed and used in the present study.

Although no definite CD4+CD8- thymocytes were observed in TKO mice lacking MHC class I and class II expression, significant numbers of CD4+CD8- thymocytes were selected to mature on a single I-Ab-Ealpha 52-68 complex in B2L TKO, reaching a level of ~25% of that seen in mice that express wild-type I-Ab molecules but lack beta 2-microglobulin expression (beta 20/0; Fig. 1 A). Although the proportion of CD4+CD8- thymocytes in B2L TKO was comparable to that in B2L DKO, CD4+CD8int thymocytes markedly decreased in B2L TKO. Such a decrease, compared with DKO or C57BL/6 (B6) mice, was also found in TKO and beta 20/0 mice. These observations are consistent with the previous report (37), supporting the model that CD4+CD8int population represents developing thymocytes to CD4-CD8+ phenotype as well as those to CD4+CD8- phenotype (38). When NK1.1 expression was analyzed in B2L DKO, around 10% of CD4+CD8- thymocytes expressed this surface marker. However, as we expected, CD4+CD8-NK1.1+ T cells were scarcely observed in the thymus from B2L TKO (Fig. 1 B).


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 1.   CD4+ T cell differentiation in B2L TKO and B2L DKO mice. (A) Thymocytes were prepared from six different lines (DKO, B2L DKO, B6, TKO, B2L TKO, and beta 20/0) at 6-7 wk old and analyzed for CD4 and CD8 expression. The percentages of CD4+CD8-, CD4+CD8int, CD4+CD8+, and CD4-CD8+ thymocytes are indicated. The data represent at least three independent experiments. The mean ± one SD for the percentage of CD4+CD8- and CD4+CD8int thymocytes in each line are as follows: DKO, 0.7 ± 0.1% and 1.9 ± 0.1%; B2L DKO, 2.0 ± 0.4% and 2.5 ± 0.4%; B6, 7.2 ± 0.5% and 2.8 ± 0.3%; TKO, 0.4 ± 0.1% and 0.3 ± 0.0%; B2L TKO, 2.0 ± 0.3% and 0.4 ± 0.1%; beta 20/0, 8.3 ± 0.5% and 1.7 ± 0.0%. (B) The expression of NK1.1 on CD4+CD8- thymocytes is compared between B2L DKO (left, dotted line) and B2L TKO (left, solid line) or between B6 (right, dotted line) or beta 20/0 (right, solid line). The percentage of CD4+CD8-NK1.1+ thymocytes in mice with or without MHC class I expression are indicated above or below the line, respectively. For each line, at least two mice were analyzed. The each value for the percentage of CD4+CD8-NK1.1+ thymocytes to total CD4+CD8- thymocytes was as follows: B2L DKO, 11.3, 7.9, 8.9; B2L TKO, 0.4, 0.8, 0.7; B6, 1.6, 2.1; beta 20/0, 0.1, 0.1.

CD4+CD8- Thymocytes Selected to Mature on the I-Ab- Ealpha 52-68 Complex Express Diverse TCR-alpha Chains with No Obvious Structural Features.

In an attempt to assess the role of self-peptides in shaping a mature T cell repertoire, we first compared the TCR Vbeta usages in CD4+CD8- thymocytes from B2L TKO with those from beta 20/0 mice, using a panel of mAbs. Although the proportions of CD4+CD8- thymocytes expressing TCR Vbeta 4, 12, and 14 slightly increased in B2L TKO (Vbeta 4, 12.7 ± 0.5% vs. 8.3 ± 0.3%; Vbeta 12, 3.7 ± 0.5% vs. 2.7 ± 0.1%; Vbeta 14, 12.7 ± 0.7% vs. 10.2 ± 0.2%), other TCR Vbeta were similarly expressed on CD4+CD8- thymocytes in these lines (data not shown).

In contrast to the availability of the mAbs specific for TCR Vbeta segments, only limited numbers of mAbs are available for TCR Valpha s, some of which react with only the subfamily of a particular TCR Valpha family. To overcome this problem and thoroughly analyze the TCR-alpha repertoire, we sorted CD4+CD8- thymocytes and examined TCR-alpha mRNA using anchored PCR followed by sequencing of the cloned PCR products. From B2L TKO CD4+CD8- thymocytes, we obtained 97 clones originating from different templates, where 13 different Valpha families and 27 different Jalpha segments were encoded. On the other hand, we obtained from beta 20/0 CD4+CD8- thymocytes 71 independent TCR-alpha sequences that encoded 13 different Valpha families and 22 different Jalpha segments. When the Valpha and Jalpha usages were compared, no remarkable difference was observed (Fig. 2 A and data not shown). The distribution of CDR3 length showed Gaussian-like patterns in both cases (Fig. 2 B). In addition, no obvious structural features in the CDR3 loops could be deduced, even when clones from B2L TKO were analyzed (data not shown). These results indicate that a single ligand, I-Ab- Ealpha 52-68 complex, selects a quite diverse T cell repertoire.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Valpha usage (A) and CDR3 length distribution (B) of TCR-alpha repertoire shaped by the I-Ab-Ealpha 52-68 complex. CD4+CD8- thymocytes were sorted from B2L TKO or beta 20/0 mice, and TCR-alpha transcripts were analyzed using anchored PCR followed by sequencing of the cloned PCR products. The results are shown as the percentages of clones originating from different templates. The clones encoding undefined TCR Valpha are indicated as U.D. in A. CDR3 length in (B) is indicated as the number of amino acid residues between two amino acids downstream from the conserved cysteine at position 90 in the V region and two amino acids upstream from the conserved GXG motif (where G is glycine and X is any amino acid) in the J region (64).

CD4+ T Cell Differentiation Directed by the I-Ab-Ealpha 52-68 Complex in the Presence of a Single Rearranged TCR-beta chain.

The specificity of TCR for MHC-peptide ligands is determined by both TCR-alpha and beta  chains. In light of the low affinity interaction of TCR-alpha /beta with MHC-peptide ligands in positive selection (31), it would be difficult to visualize the imprint of selecting peptides on T cell repertoire when TCR-alpha or TCR-beta chains are separately analyzed, even though selecting peptide is a single species. However, some structural imprints might be revealed, if TCR-alpha or TCR-beta chains were to be analyzed for CD4+CD8- thymocytes expressing a particular TCR-beta or TCR-alpha with irrelevant specificity for the selecting ligand. To test this idea, we employed the transgenic mice expressing 2B4 TCR-beta (Vbeta 3-Dbeta 1.1-Jbeta 1.2) derived from the TCR-alpha /beta specific for moth cytochrome c peptide bound to I-Ek or I-Eb molecules (7, 39), and, by crossing these mice with B2L TKO, developed TKO mice expressing both B2L transgene and the rearranged 2B4 TCR-beta (B2L TKO/2B4beta ).

Although no CD4+CD8- thymocytes were observed in TKO/2B4beta mice lacking MHC class I and class II expression, significant numbers of CD4+CD8- thymocytes were selected to mature in B2L TKO/2B4beta and beta 20/0 mice expressing 2B4 TCR-beta chain (beta 20/0/2B4beta ; Fig. 3 A). Lymph node CD4+ T cells from B2L TKO/2B4beta mice as well as B2L TKO responded well to spleen cells from beta 20/0 or C57BL/6 (B6) mice expressing wild-type I-Ab molecules with self-peptides other than Ealpha 52-68, but did not show any response to B2H TKO spleen cells that express I-Ab- Ealpha 52-68 complex as a single species at higher level than those from B2L TKO (24; Fig. 3 B). Taken together, these observations suggest that positive and negative selection occurs normally in immature thymocytes expressing the essentially fixed 2B4 TCR-beta and randomly rearranged TCR-alpha in B2L TKO/2B4beta mice.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   Phenotypic and functional analysis for CD4+ T cell differentiation directed by the I-Ab-Ealpha 52-68 complex in the presence of the 2B4 TCR-beta chain. (A) Thymocytes were prepared from TKO/2B4beta , B2L TKO/2B4beta , and beta 20/0/2B4beta mice at 6-7 wk old and analyzed for CD4 and CD8 expression. The percentages of CD4+CD8-, CD4+CD8int, CD4+CD8+, CD4-CD8+ thymocytes are indicated. For each line, at least three mice were analyzed. The each value for the percentage of CD4+CD8- thymocytes was as follows: TKO/2B4beta , 0.1, 0.1, 0.1; B2L TKO/2B4beta , 1.3, 0.9, 0.7, 0.7; beta 20/0/2B4beta , 2.6, 2.3, 2.7. (B) Lymph node CD4+ T cells from B2L TKO/2B4beta or B2L TKO mice were cultured with irradiated spleen cells from B2H TKO, B6, and beta 20/0 mice, and [3H]thymidine incorporation was measured. The data indicate the mean plus one SD of triplicate cultures. (C) Thymocytes were prepared from B2L TKO/2B4beta or beta 20/0/2B4beta mice at 6-7 wk old, and the expression of TCR Vbeta 3 was analyzed for gated CD4+CD8- thymocytes (top). The percentages of CD4+CD8-Vbeta 3-, CD4+CD8-Vbeta 3int, CD4+CD8-Vbeta 3hi thymocytes are indicated. For each line, four or three mice were analyzed. The each value for the percentage of CD4+ CD8-Vbeta 3hi thymocytes was as follows: B2L TKO/2B4beta , 64.7, 71.0, 65.2, 75.0; beta 20/0/2B4beta , 69.3, 75.3, 70.8. The expression of TCR Vbeta 8 on CD4+CD8-Vbeta 3hi, CD4+CD8-Vbeta 3int, CD4+CD8-Vbeta 3- thymocytes and the percentages of positive population are shown below.

When the expression of TCR Vbeta 3 was analyzed, 65- 75% of CD4+CD8- thymocytes from both B2L TKO/ 2B4beta and beta 20/0/2B4beta mice expressed on their cell surface TCR Vbeta 3 at a high level (Fig. 3 C). Considerable numbers of CD4+CD8-Vbeta 3- and CD4+CD8-Vbeta 3int thymocytes expressed TCR Vbeta 8 that is most frequently observed in CD4+CD8- thymocytes from both B2L TKO and beta 20/0 mice (B2L TKO, 18.0 ± 0.4%; beta 20/0, 18.2 ± 0.5%), whereas no definite expression of TCR Vbeta 8 was detected on CD4+CD8- thymocytes expressing TCR Vbeta 3 at a high level from both B2L TKO/2B4beta and beta 20/0/2B4beta (Fig. 3 C). These observations indicate that allelic exclusion by the transgenic 2B4 TCR-beta is almost completed in CD4+CD8-Vbeta 3hi thymocytes and suggest that these thymocytes exclusively express the transgene.

Highly Restricted Expression of TCR-alpha Chains on CD4+CD8- Thymocytes Selected to Mature on the I-Ab- Ealpha 52-68 Complex in the Presence of Transgenic 2B4 TCR-beta .

With the strategy described above, we then compared TCR-alpha chains expressed on CD4+CD8-Vbeta 3hi thymocytes from B2L TKO/2B4beta with those from beta 20/0/ 2B4beta or B6 mice expressing both Ealpha and 2B4 TCR-beta chains (Ealpha -B6/2B4beta ). In two independent experiments using different B2L TKO/2B4beta mice, 73 out of 109 clones (67%) originating from different templates were found to encode the Valpha 18 family, and 42% of the remaining (15 of 36 clones) encoded the Valpha segment (denoted as 17.A2) that was not observed in samples from beta 20/0/2B4beta mice but identical to that on a T cell clone reported by Mohapatra et al. (40; Fig. 4 A). In contrast to the results on B2L TKO/2B4beta mice, such restricted TCR Valpha usage was not observed with clones obtained from Ealpha -B6/2B4beta or beta 20/0/ 2B4beta mice expressing wild-type I-Ab molecules with or without I-Ab-Ealpha 52-68 complex, respectively, though the TCR Valpha repertoire differed between these strains, probably because of the presence of I-Eb molecules in Ealpha -B6/ 2B4beta mice. When the length of their CDR3 loops was compared, the distribution pattern in B2L TKO/2B4beta mice differed from those in beta 20/0/2B4beta and Ealpha -B6/2B4beta (Fig. 4 B).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Valpha usage (A) and CDR3 length distribution (B) of TCR-alpha repertoire shaped by the I-Ab-Ealpha 52-68 complex in the presence of 2B4 TCR-beta chain. CD4+CD8-Vbeta 3hi thymocytes were sorted from B2L TKO/ 2B4beta , beta 20/0/2B4beta , or Ealpha -B6/ 2B4beta mice, and TCR-alpha transcripts were analyzed, as described for Fig. 2. The results are shown as percentages of clones originating from different templates. The closed and hatched boxes represent clones obtained from independent experiments using different mice. The clones encoding undefined Valpha are indicated as U.D. in A.

Having found that CD4+CD8- thymocytes selected to mature on I-Ab-Ealpha 52-68 complex preferentially expressed Valpha 18 in the presence of the 2B4 TCR-beta , we focused on clones encoding this Valpha family and analyzed amino acid sequences of their CDR3 loops. Surprisingly, 70 of 73 clones bearing Valpha 18 from B2L TKO/2B4beta mice encoded aspartic or glutamic acid at the first position of their CDR3 loops (alpha 93; Table 1). In contrast, only 9 of 20 clones bearing Valpha 18 from beta 20/0/2B4beta encoded aspartic or glutamic acid at alpha 93, and 11 other clones encoded several amino acid residues including tryptophan, alanine, arginine, proline, valine, threonine, glycine, and leucine (Table 1). The Valpha 18 family includes two subfamilies, AV18S1 and AV18S2, that only differ by the amino acid residue at position 25: AV18S1 encodes threonine at this position, whereas AV18S2 encodes lysine (41). Although the subfamily was not determined for 23 clones from B2L TKO/2B4beta mice due to shortness of the PCR products, 50 other clones encoded AV18S2 and 48 clones of these encoded aspartic or glutamic acid at alpha 93. Because of the lack of complete information on the genomic sequence of AV18S2, we cannot determine at this stage whether aspartic or glutamic acid at this position is encoded by a germ line sequence or created by a random nucleotide (N-region) addition. Nonetheless, since the AV18S2-bearing TCR-alpha chains with various amino acid residues at alpha 93 were found in beta 20/0/2B4beta , it is suggested that, in B2L TKO/2B4beta mice, there is a strong selection to conserve or introduce negatively charged amino acid residues at this position to survive the thymic selection directed by a single I-Ab-Ealpha 52-68 ligand.

                              
View this table:
[in this window]
[in a new window]
 

Table 1
Comparison of Valpha 18-encoding TCR-alpha Chains between B2L TKO/2B4beta and beta 20/0/2B4beta Mice

Since AV18S2 and Valpha 17.A2 were the major Valpha gene segments obtained from B2L TKO/2B4beta , we compared the NH2-terminal structure of these segments from the cysteine at position 90. As shown in Fig. 5 A, the predicted amino acid sequences are highly conserved between these Valpha gene segments (80.7%). The CDR1 and CDR2 loops of TCR-alpha chains have been suggested to play an important role in interactions with MHC class II/peptide ligand (42). Although three amino acid substitutions are observed in their CDR1 loops, the property of these amino acid residues is relatively conserved and the CDR2 loops show no differences between AV18S2 and Valpha 17.A2. Thus, it is concluded that Valpha 17.A2 encodes the Valpha chain that would be structurally related to that encoded by AV18S2. When CDR3 loops were analyzed for 15 clones encoding Valpha 17.A2 from B2L TKO/2B4beta mice, we again found that 11 clones encoded aspartic or glutamic acid at alpha 93 (Fig. 5 B).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 5.   Predicted amino acid sequence of Valpha 17.A2-encoding TCR-alpha chains. (A) The NH2-terminal structure of Valpha 17.A2 from cysteine at position 90 is compared with that of AV18S2. CDR1 and CDR2 are boxed. (B) The clones originating from different templates were analyzed for CDR3 loops and Jalpha gene segments.

    Discussion
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In this study, we compared the TCR-alpha repertoire in CD4+CD8- thymocytes selected to mature on a single I-Ab-Ealpha 52-68 ligand with those selected by wild-type I-Ab molecules with a normal array of self-peptides, in the presence or absence of a single rearranged TCR-beta chain irrelevant to this selecting ligand, using anchored PCR followed by sequencing of the PCR products. This method is based on competitive PCR without using specific primers for particular Valpha segments, so that PCR bias is minimized. In addition, clones originating from different templates can be distinguished by differences in the anchored position, even when they encode the same TCR-alpha chains. Although the frequencies of Valpha 3 or Valpha 8 usage in B2L TKO and beta 20/0 mice estimated using this approach were much higher than frequencies assessed using the mAbs, RR3-16 or B21.14 (data not shown), this is likely the result of specificity of these mAbs that react with only some of these subfamilies (45, 46). On the other hand, the frequencies of Valpha 2 usage estimated by this approach in several mouse lines including B2L TKO, beta 20/0, and B2L TKO/2B4beta largely agreed with frequencies observed with the flow cytometric analysis using the mAb, B20.1, that reacts with almost all subfamilies (47; data not shown). Therefore, we conclude that heterogeneity of the anchored PCR products would reflect, to some extent, the real diversity of TCR-alpha repertoire in CD4+CD8- thymocytes.

By introducing the 2B4 TCR-beta chain with irrelevant specificity for the I-Ab-Ealpha 52-68 complex, CD4+CD8- thymocytes selected to mature on this single ligand expressed highly restricted TCR-alpha chains encoding Valpha 18 or its related sequence and negatively charged amino acid residues at alpha 93 in their CDR3 loops. Taking into consideration that multiple TCR-alpha rearrangements cease only after positive selection (48, 49), a small number of clones encoding TCR-alpha chains without such structural features might represent nonselectable in-frame rearrangements (50). Alternatively, these clones might be derived from a trace of CD4+CD8-Vbeta 3int thymocytes where allelic exclusion by 2B4 TCR-beta is not accomplished. Since such structural features of TCR-alpha chain were not observed with CD4+CD8-Vbeta 3hi thymocytes selected to mature in beta 20/0/2B4beta mice expressing wild-type I-Ab molecules with a normal array of self-peptides, it is clear that highly restricted Valpha usage and amino acid residues at alpha 93 in B2L TKO/2B4beta mice does not result from efficient pairing of particular TCR-alpha chains with 2B4 TCR-beta as was previously reported (51, 52), but rather from thymic selection directed by I-Ab-Ealpha 52-68 complex. We cannot determine at this stage whether aspartic or glutamic acid at alpha 93 is determined by the germ line sequence or created by the N-region. However, it is suggested that both structural features in the Valpha gene segment and amino acid residue at alpha 93 are independently required to survive thymic selection by this single ligand, because other Valpha gene segments, including AV10S6 that encodes aspartic acid at this position in its germ line (41), are not preferentially expressed in CD4+ CD8-Vbeta 3hi thymocytes from B2L TKO/2B4beta mice and AV18S2-bearing clones from beta 20/0/2B4beta mice were found to encode various amino acid residues at this position. We have shown that lymph node CD4+ T cells from B2L TKO/2B4beta mice acquire immunological tolerance to the I-Ab-Ealpha 52-68 complex, suggesting that the T cell repertoire in this line is shaped through both positive and negative selection directed by a I-Ab-Ealpha 52-68 ligand. This might raise the possibility that developing thymocytes expressing TCR-alpha chains other than those with the particular Valpha segments and CDR3 loops are eliminated in B2L TKO/2B4beta mice through interaction with I-Ab-Ealpha 52-68 complexes that are expressed in this line but not in beta 20/0/ 2B4beta mice. However, this possibility is unlikely, because various TCR-alpha chains without such structural features were found in CD4+CD8-Vbeta 3hi thymocytes from Ealpha -B6/2B4beta mice where I-Ab-Ealpha 52-68 complexes are expressed in the thymus, probably at higher level than that in B2L TKO/2B4beta (34). Therefore, it is suggested that the structural features of TCR-alpha chains observed in B2L TKO/2B4beta mice are imprinted under the process of positive selection directed by I-Ab-Ealpha 52-68 complex.

Several groups recently reported that antigen-specific T cells selected by a given MHC-peptide complex express somewhat different TCR from those in normal mice, suggesting that selecting self-peptides influence mature T cell repertoire (53). However, it is difficult from these experiments to precisely determine whether the altered T cell repertoire mainly results from positive selection directed by a particular MHC-peptide ligand or antigen-driven expansion of some T cells that would be deleted in normal mice expressing the same MHC class II molecules at high level in the thymus with a normal array of self-peptides, because negative selection to wild-type MHC molecules was lacking in some experiments (54) or was ineffective (53, 55). This issue was clarified in this study where CD4+CD8- thymocytes positively selected by a single I-Ab-Ealpha 52-68 ligand were directly analyzed for TCR-alpha chains expressed in association with 2B4 TCR-beta . Our findings clearly indicate that self-peptides involved in positive selection influence structure of the variable gene segment and CDR3 loops of the selected TCR repertoire. In some antigen-specific TCR recognition, the amino acid residue at alpha 93 has been functionally or structurally shown to be involved in peptide contact (56, 57). Thus, the highly restricted amino acid residue at this position of TCR-alpha chains in B2L TKO/2B4beta mice strongly suggests that specific TCR- peptide contacts are also involved in positive selection directed by I-Ab-Ealpha 52-68 complex. Since expression of the I-Ab-Ealpha 52-68 complex was readily detected in the thymus using a mAb specific for this complex (24), it is unlikely that this contribution of Ealpha 52-68 to positive selection in B2L TKO/2B4beta mice is due to an extremely low expression of I-Ab molecules, which might cause a more stringent requirement of specific selecting peptides than that under physiological conditions. In addition, CD4+CD8- thymocytes in B2L TKO/2B4beta mice, different from studies using TCR-alpha /beta transgenic mice, are selected from the semidiverse T cell repertoire with randomly rearranged TCR-alpha chains and the essentially fixed 2B4 TCR-beta chain. Although further analysis needs to address whether self-peptides with amino acid residues bearing bulky or charged side chains at positions facing TCR would mediate efficient positive selection, our findings on B2L TKO/2B4beta mice provide definitive evidence that specific recognition of self-peptides by TCR is involved in positive selection of thymocytes and support the recent observation that the amino acid composition of CDR3 loops analyzed for particular Vbeta -Jbeta segments in B2L DKO mice is slightly different from those in B6 mice (58).

Studies on crystallography of two MHC class I-peptide complexes with their associated TCR-alpha /beta have revealed that five CDs both from TCR-alpha and TCR-beta chains, except for TCR-beta CDR2, directly interact with MHC class I-peptide complex in a diagonal orientation (57, 59). Although no structural data are available for the interaction of TCR-alpha /beta with MHC class II-peptide complex, functional studies have suggested that a similar but not identical interaction also occurs in this case (43, 44). Since CDR1 and CDR2 are determined by a variable segment itself, our finding on B2L TKO/2B4beta mice that developing thymocytes expressing TCR-alpha chains with particular Valpha segments and CDR3 loops are allowed to mature on a single MHC-peptide ligand suggests that at least two good fits are required for the interaction of TCR-alpha /beta with a selecting ligand to survive positive selection. Despite this requirement, however, TCR-alpha chains expressed on CD4+CD8- thymocytes from B2L TKO mice showed no obvious bias in Valpha usage and amino acid composition of their CDR3 loops. By analyzing the affinity of TCR-alpha /beta for positively or negatively selecting MHC-peptide ligands in a cell-free system, Alam et al. (31) have suggested that the affinity window to survive both positive and negative selection is quite narrow. Therefore, provided that a TCR-beta chain has CDR1 or CDR3 that fits with a selecting ligand, CDR of the associated TCR-alpha chain on mature thymocytes would be less characteristic, because not only of low affinity interaction sufficient for surviving positive selection but also of negative selection of developing thymocytes expressing TCR-alpha chains with good fits. Together with the degeneracy in recognition of peptides by TCR-alpha /beta (60), this could explain why B2L TKO/2B4beta mice but not B2L TKO show structural features in their mature TCR-alpha repertoire. Although the degree of this structural fitness for a selecting MHC-peptide ligand would be affected by its cell surface density in thymic cortex and medulla (17, 24, 61), the partial fitness of TCR-alpha /beta for their selecting peptide and/or MHC molecule might be a general feature of the mature T cell repertoire shaped by both positive and negative selection.

Although H-2M0/0 mice had been used to define the role of particular self-peptides in positive selection (21, 25, 27), it has been shown that peptides other than CLIP are bound to I-Ab molecules and contribute to the positive selection of CD4+ thymocytes (26). By comparing a particular Valpha -Jalpha segment in H-2M0/0 mice with that in H-2M0/+ in the presence of a single rearranged TCR-beta chain, Sant'Angelo et al. (30) recently reported that alteration of self-peptides bound to I-Ab molecules affects CDR3 length of the selected TCR-alpha repertoire. The somewhat biased distribution of CDR3 length observed with the TCR-alpha repertoire in B2L TKO/2B4beta mice largely supports their findings. However, it should be noted that homogeneity in the CDR3 length in B2L TKO/2B4beta mice depends on the analyzed Valpha -Jalpha segments: 12 out of 12 clones encoding Valpha 17.A2-Jalpha 15 have the same CDR3 length, whereas this is not the case with the Valpha 18-Jalpha 20 segment where 16 clones have a CDR3 loop of 7 amino acids, 18 clones have a CDR3 loop of 8 amino acids, and 1 clone has a CDR3 loop of 9 amino acids. Therefore, different from the case with antigen-driven T cell expansion (62, 63), our findings in B2L TKO/2B4beta mice suggest that homogeneity in the CDR3 length does not serve as a hallmark of specific TCR-peptide interaction in the positive selection of thymocytes. In addition, the TCR-alpha repertoire in B2L TKO/ 2B4beta mice, as compared with that in H-2M0/0 mice expressing the transgenic TCR-beta chain, showed a stronger restriction to amino acid residue in the CDR3 loops. This would result from differences in the expression level of I-Ab molecules in the thymus and/or the diversity of selecting peptides, that is single or heterogeneous. Furthermore, the difference in the introduced TCR-beta chain might affect the outcome, because D10 TCR-beta chain used in their experiment is derived from the I-Ab-reactive TCR-alpha /beta (42).

In conclusion, we have shown that, by expression of a single rearranged TCR-beta chain with irrelevant specificity for the selecting ligand, CD4+CD8- thymocytes selected to mature on a single MHC class II-peptide ligand express highly restricted TCR-alpha chains in terms of Valpha usage and amino acid residue of their CDR3 loops, thereby providing evidence for specific recognition of self-peptides by TCR-alpha /beta in positive selection. Thus, our experimental system made it feasible to visualize TCR structure required for surviving positive selection directed by a single MHC- peptide ligand. This approach would lead to the relevant application for elucidation of topology of TCR-MHC-peptide interaction in positive selection.

    Footnotes

Address correspondence to Takehiko Sasazuki, Kyushu University, Medical Institute of Bioregulation, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Phone: (81) 92-642-6828; Fax: (81) 92-632-0150; E-mail: sasazuki{at}bioreg.kyushu-u.ac.jp

Received for publication 20 April 1998 and in revised form 17 June 1998.

The authors thank Drs. D. Mathis and C. Benoist for mice deficient in wild-type I-Abeta b or invariant chain, Dr. M.M. Davis for 2B4beta transgenic mice, M. In and H. Kuriki for assistance with cell sorting, and M. Ohara for comments on the manuscript.

This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture, Japan and the Japan Science and Technology Corporation.

Abbreviations used in this paper beta 20/0, mice lacking beta 2-microglobulin; B2L or B2H, mouse lines expressing I-Abeta b chain covalently bound to Ealpha 52-68; B6, C57BL/6 mice; CLIP, invariant chain-derived class II-associated peptide; DKO, mice lacking endogenous I-Abeta b and invariant chains; Ealpha 52-68, Ealpha -derived peptide; Ealpha -B6, C57BL/6 mice transgenic for Ealpha ; H-2M0/0, mice lacking H-2M expression; TKO, mice lacking endogenous I-Abeta b, invariant chain, and beta 2-microglobulin; TKO/2B4beta , B2L TKO/2B4beta , beta 20/0/2B4beta , Ealpha -B6/2B4beta ; TKO, B2L TKO, beta 20/0 and Ealpha -B6 mice expressing 2B4 TCR-beta chain.

    References
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1. Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature. 334: 395-402 [Medline].
2. Bevan, M.J.. 1977. In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature. 269: 417-418 [Medline].
3. Zinkernagel, R.M., G.N. Callahan, A. Althage, S. Cooper, P.A. Klein, and J. Klein. 1978. On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J. Exp. Med. 147: 882-896 [Abstract].
4. Kisielow, P., H.S. Teh, H. Blüthmann, and H. von Boehmer. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 335: 730-733 [Medline].
5. Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell, and D.Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335: 271-274 [Medline].
6. Teh, H.-S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Blüthmann, and H. von Boehmer. 1988. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature. 335: 229-233 [Medline].
7. Berg, L.J., A.M. Pullen, B. Fazekas de St, Growth, B. Groth, D. Mathis, C. Benoist, and M.M. Davis. 1989. Antigen/ MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell. 58: 1035-1046 [Medline].
8. Kappler, J.W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell. 49: 273-280 [Medline].
9. Kisielow, P., H. Blüthmann, U.D. Staerz, M. Steinmetz, and H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 333: 742-746 [Medline].
10. MacDonald, H.R., R. Schneider, R.K. Lees, R.C. Howe, H. Acha, Orbea, H. Festenstein, R.M. Zinkernagel, and H. Hengartner. 1988. T-cell receptor V beta  use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 332: 40-45 [Medline].
11. Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell, and D.Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature. 336: 73-76 [Medline].
12. Murphy, K.M., A.B. Heimberger, and D.Y. Loh. 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250: 1720-1723 [Medline].
13. Allen, P.M.. 1994. Peptides in positive and negative selection: a delicate balance. Cell. 76: 593-596 [Medline].
14. Bevan, M.J.. 1997. In thymic selection, peptide diversity gives and takes away. Immunity. 7: 175-178 [Medline].
15. Ashton-Rickardt, P.G., L. Van Kaer, T.N.M. Schumacher, H.L. Ploegh, and S. Tonegawa. 1993. Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell. 73: 1041-1049 [Medline].
16. Hogquist, K.A., M.A. Gavin, and M.J. Bevan. 1993. Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J. Exp. Med. 177: 1469-1473 [Abstract].
17. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76: 17-27 [Medline].
18. Ashton-Rickardt, P.G., A. Bandeira, J.R. Delaney, L. Van Kaer, H.-P. Pircher, R.M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 76: 651-663 [Medline].
19. Sebzda, E., V.A. Wallace, J. Mayer, R.S.M. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 263: 1615-1618 [Medline].
20. Ignatowicz, L., J. Kappler, and P. Marrack. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell. 84: 521-529 [Medline].
21. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 84: 531-541 [Medline].
22. Martin, W.D., G.G. Hicks, S.K. Mendiratta, H.I. Leva, H.E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84: 543-550 [Medline].
23. Fung-Leung, W.-P., C.D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P.A. Peterson, S.R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science. 271: 1278-1281 [Abstract].
24. Fukui, Y., T. Ishimoto, M. Utsuyama, T. Gyotoku, T. Koga, K. Nakao, K. Hirokawa, M. Katsuki, and T. Sasazuki. 1997. Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity. 6: 401-410 [Medline].
25. Tourne, S., T. Miyazaki, A. Oxenius, L. Klein, T. Fehr, B. Kyewski, C. Benoist, and D. Mathis. 1997. Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice. Immunity. 7: 187-195 [Medline].
26. Grubin, C.E., S. Kovats, P. deRoos, and A.Y. Rudensky. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity. 7: 197-208 [Medline].
27. Surh, C.D., D.-S. Lee, W.-p. Fung-Leung, L. Karlsson, and J. Sprent. 1997. Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity. 7: 209-219 [Medline].
28. Hu, Q., C.R.B. Walker, C. Girao, J.T. Opferman, J. Sun, J. Shabanowitz, D.F. Hunt, and P.G. Ashton-Rickardt. 1997. Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity. 7: 221-231 [Medline].
29. Schumacher, T.N.M., and H.L. Ploegh. 1994. Are MHC-bound peptides a nuisance for positive selection? Immunity. 1: 721-723 [Medline].
30. Sant'Angelo, D.B., P.G. Waterbury, B.E. Cohen, W.D. Martin, L. Van Kaer, A.C. Hayday, and C.A. Janeway Jr.. 1997. The imprint of intrathymic self-peptides on mature T cell receptor repertoire. Immunity. 7: 517-524 [Medline].
31. Alam, S.M., P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature. 381: 616-620 [Medline].
32. Hedrick, S.M., L.A. Matis, T.T. Hecht, L.E. Samelson, D.L. Longo, E. Heber-Katz, and R.H. Schwartz. 1982. The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell. 30: 141-152 [Medline].
33. Fukui, Y., K. Yamamoto, T. Koga, K. Yamane, and T. Sasazuki. 1997. Differential requirement of MHC class II molecules expressed on hematopoietic cells for positive selection of CD4+ thymocytes in TCRalpha beta and TCR-beta transgenic mice. Int. Immunol. 9: 1385-1391 [Abstract].
34. Yamamura, K., H. Kikutani, V. Folsom, L.K. Clayton, M. Kimoto, S. Akira, S.-i. Kashiwamura, S. Tonegawa, and T. Kishimoto. 1985. Functional expression of a microinjected Ealpha d gene in C57BL/6 transgenic mice. Nature. 316: 67-69 [Medline].
35. Bendelac, A., N. Killeen, D.R. Littman, and R.H. Schwartz. 1994. A subset of CD4+ thymocytes selected by MHC class I molecules. Science. 263: 1774-1778 [Medline].
36. Bendelac, A., O. Lantz, M.E. Quimby, J.W. Yewdell, J.R. Bennink, and R.R. Brutkiewicz. 1995. CD1 recognition by mouse NK1+ lymphocytes. Science. 268: 863-865 [Medline].
37. Chan, S.H., D. Cosgrove, C. Waltzinger, C. Benoist, and D. Mathis. 1993. Another view of the selective model of thymocyte selection. Cell. 73: 225-236 [Medline].
38. Lucas, B., and R.N. Germain. 1996. Unexpectedly complex regulation of CD4/CD8 coreceptor expression supports a revised model for CD4+CD8+ thymocyte differentiation. Immunity. 5: 461-477 [Medline].
39. Berg, L.J., G.D. Frank, and M.M. Davis. 1990. The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell. 60: 1043-1053 [Medline].
40. Mohapatra, S., Y. Chen, M. Takata, S.S. Mohapatra, and A.H. Sehon. 1993. Analysis of T-cell receptor alpha beta chains of CD8+ suppressor T cells induced by tolerogenic conjugates of antigen and monomethoxypolyethylene glycol. Involvement of TCR alpha -CDR3 domain in immunosuppression. J. Immunol. 151: 688-698 [Abstract/Free Full Text].
41. Arden, B., S.P. Clark, D. Kabelitz, and T.W. Mak. 1995. Mouse T-cell receptor variable gene segment families. Immunogenetics. 42: 501-530 [Medline].
42. Hong, S.-C., A. Chelouche, R.-h. Lin, D. Shaywitz, N.S. Braunstein, L. Glimcher, and C.A. Janeway Jr.. 1992. An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha  chain variable domain. Cell. 69: 999-1009 [Medline].
43. Sant'Angelo, D.B., G. Waterbury, P. Preston-Hurlburt, S.T. Yoon, R. Medzhitov, S.-c. Hong, and C.A. Janeway Jr.. 1996. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity. 4: 367-376 [Medline].
44. Hong, S.-c., D.B. Sant'Angelo, B.N. Dittel, R. Medzhitov, S.T. Yoon, P.G. Waterbury, and C.A. Janeway Jr.. 1997. The orientation of a T cell receptor to its MHC class II:peptide ligands. J. Immunol. 159: 4395-4402 [Abstract].
45. Utsunomiya, Y., J. Bill, E. Palmer, K. Gollob, Y. Takagaki, and O. Kanagawa. 1989. Analysis of a monoclonal rat antibody directed to the alpha -chain variable region (V alpha  3) of the mouse T cell antigen receptor. J. Immunol. 143: 2602-2608 [Abstract/Free Full Text].
46. Necker, A., N. Rebai, M. Matthes, E. Jouvin-Marche, P.-A. Cazenave, P. Swarnworawong, E. Palmer, H.R. MacDonald, and B. Malissen. 1991. Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for Valpha 8-, Vbeta 2- or Vbeta 10-bearing T cells. Eur. J. Immunol. 21: 3035-3040 [Medline].
47. Pircher, H., N. Rebai, M. Groettrup, C. Grégoire, D.E. Speiser, M.P. Happ, E. Palmer, R.M. Zinkernagel, H. Hengartner, and B. Malissen. 1992. Preferential positive selection of V alpha  2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor Valpha a haplotypes: determination with a V alpha  2-specific monoclonal antibody. Eur. J. Immunol. 22: 399-404 [Medline].
48. Turka, L.A., D.G. Schatz, M.A. Oettinger, J.J.M. Chun, C. Gorka, K. Lee, W.T. McCormack, and C.B. Thompson. 1991. Thymocyte expression of RAG-1 and RAG-2: Termination by T cell receptor cross-linking. Science. 253: 778-781 [Medline].
49. Borgulya, P., H. Kishi, Y. Uematsu, and H. von Boehmer. 1992. Exclusion and inclusion of alpha  and beta  T cell receptor alleles. Cell. 69: 529-537 [Medline].
50. Malissen, M., J. Trucy, M.E. Jouvin, P.A. Cazenave, R. Scollay, and B. Malissen. 1992. Regulation of TCR alpha  and beta  gene allelic exclusion during T-cell development. Immunol. Today. 13: 315-322 [Medline].
51. Saito, T., and R.N. Germain. 1989. Marked differences in the efficiency of expression of distinct alpha  beta  T cell receptor heterodimers. J. Immunol. 143: 3379-3384 [Abstract/Free Full Text].
52. Uematsu, Y.. 1992. Preferential association of alpha  and beta  chains of the T cell antigen receptor. Eur. J. Immunol. 22: 603-606 [Medline].
53. Nakano, N., R. Rooke, C. Benoist, and D. Mathis. 1997. Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science. 275: 678-683 [Abstract/Free Full Text].
54. Ignatowicz, L., W. Rees, R. Pacholczyk, H. Ignatowicz, E. Kushnir, J. Kappler, and P. Marrack. 1997. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity. 7: 179-186 [Medline].
55. Liu, C.-P., D. Parker, J. Kappler, and P. Marrack. 1997. Selection of antigen-specific T cells by a single IEk peptide combination. J. Exp. Med. 186: 1441-1450 [Abstract/Free Full Text].
56. Jorgensen, J.L., U. Esser, B. Fazekas de St, Groth, P.A. Reay, and M.M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 355: 224-230 [Medline].
57. Garboczi, D.N., P. Ghosh, U. Utz, Q.R. Fan, W.E. Biddison, and D.C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384: 134-141 [Medline].
58. Gapin, L., Y. Fukui, J. Kanellopoulos, T. Sano, A. Cosrouge, V. Malier, E. Beaudoing, D. Gautheret, J.M. Claverie, T. Sasazuki, and P. Kourilsky. 1998. Quantitative analysis of the T-cell repertoire selected by a single peptide/MHC complex. J. Exp. Med. 187: 1871-1883 [Abstract/Free Full Text].
59. Garcia, K.C., M. Degano, R.L. Stanfield, A. Brunmark, M.R. Jackson, P.A. Peterson, L. Teyton, and I.A. Wilson. 1996. An alpha beta T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science. 274: 209-219 [Abstract/Free Full Text].
60. Evavold, B.D., J. Sloan-Lancaster, K.J. Wilson, J.B. Rothbard, and P.M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 2: 655-663 [Medline].
61. Cook, J.R., E.-M. Wormstall, T. Hornell, J. Russel, J.M. Connolly, and T.H. Hansen. 1997. Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo. Immunity. 7: 233-241 [Medline].
62. Cibotti, R., J.-P. Cabaniols, C. Pannetier, C. Delarbre, I. Vergnon, J.M. Kanellopoulos, and P. Kourilsky. 1994. Public and private Vbeta T cell receptor repertoires against hen egg lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180: 861-872 [Abstract].
63. McHeyzer-Williams, M.G., and M.M. Davis. 1995. Antigen-specific development of primary and memory T cells in vivo. Science. 268: 106-111 [Medline].
64. Rock, E.P., P.R. Sibbald, M.M. Davis, and Y.-h. Chien. 1994. CDR3 length in antigen-specific immune receptors. J. Exp. Med. 179: 323-328 [Abstract].

Copyright © 1998 by The Rockefeller University Press.
0022-1007/98/09/897/11 $2.00